DJIA 18,027.62 -26.09 -0.14%
NASDAQ 4,800.65 -6.21 -0.13%
S&P 500 2,088.39 -0.38 -0.02%
market minute promo

140.65 -0.81 (-0.57%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VRX $140.58 -0.62%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $140.63
Previous Close $141.46
Daily Range $140.63 - $140.63
52-Week Range $106.00 - $153.10
Market Cap $47.2B
P/E Ratio 91.86
Dividend (Yield) $0.00 (0.0%)
Volume 10,939
Average Daily Volume 2,063,782
Current FY EPS $2.96





Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website:

News & Commentary Rss Feed

Top Pharmaceutical Stocks to Buy for 2015

Three fast-growing pharmaceutical stocks that investors may want to consider owning in 2015.

Are There Any Winners Left In The Biotech Space?

Aerie: A Brilliant Future, Derisking In Progress, And The Making Of A Major Ophthalmic Pharmaceutica

Aerie: A Brilliant Future, Derisking In Progress, And The Making Of A Major Ophthalmic Pharmaceutical

Gilead/Ono Pharmaceutical Ink Deal for Blood Cancer Drug - Analyst Blog

Today's Momo Momentum Stock Is Valeant Pharmaceuticals International (VRX)

The Best Healthcare Stocks of 2014: Which Is Our Favorite for 2015?

In this week's Industry Focus, our analysts discuss their favorites of the successful 2014 healthcare large-cap stocks.

Emergent BioSolutions Buys EV-035 Series from Evolva - Analyst Blog

UCB's Kremers Urban Sale Deal Lapses, Divestiture Plan On - Analyst Blog

Cyclacel Falls on Poor Acute Myeloid Leukemia Drug Data - Analyst Blog

Insider Trading Alert - METR, VRX And EGBN Traded By Insiders

See More VRX News...

VRX's Top Competitors

VRX $140.65 (-0.57%)
Current stock: VRX
JNJ $105.28 (0.21%)
Current stock: JNJ
NVS $94.24 (0.15%)
Current stock: NVS
RHHBY $34.33 (0.29%)
Current stock: RHHBY